Analyst Moves: ESRX, GPS
November 16, 2012 at 15:11 PM EST
Express Scripts (ESRX) was upgraded by Citigroup (C) to neutral from buy with a price target of $62, as the current stock price provides an attractive entry point based on valuation for investors. Shares are higher by over 2.3 percent.
